CLINICAL-APPLICATION OF RECOMBINANT ERYTHROPOIETIN IN ANEMIC CANCER-PATIENTS

被引：21

作者：

HENRY, DH ^{[1
]}

机构：

[1] UNIV PENN,GRAD HOSP,SCH MED,DEPT MED,DIV HEMATOL ONCOL,PHILADELPHIA,PA 19104

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 1994年 / 8卷 / 05期

关键词：

D O I：

10.1016/S0889-8588(18)30141-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Anemia is common in cancer patients and may require treatment for symptomatic palliation. Transfusion has been the mainstay of therapy, but is not without risk. Because erythropoietin levels in cancer-related anemia are inadequate for the degree of anemia, recombinant human erythropoietin has been studied to treat the anemia. Results from these studies are encouraging.

引用

页码：961 / &

共 49 条

[1]

ABELS RI, 1991, BLOOD CELL GROWTH FACTORS : THEIR PRESENT AND FUTURE USE IN HEMATOLOGY AND ONCOLOGY, P121

[2]

ABELS RI, 1993, BLOOD S1, V82, P10

[3]

ADAMSON JW, 1994, SURGERY, V115, P7

[4]

ALBERTS DS, 1992, J CLIN ONCOL, V10, P683

[5]

BLUMBERG N, 1990, Transfusion Medicine Reviews, V4, P24, DOI 10.1016/S0887-7963(90)70239-8

[6] THE SIGNIFICANCE OF ANEMIA IN CLINICAL RADIATION-THERAPY [J].

BUSH, RS .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1986, 12 (11) :2047-2050

[7] RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY FOR ANEMIC CANCER-PATIENTS ON COMBINATION CHEMOTHERAPY [J].

CASE, DC ;

BUKOWSKI, RM ;

CAREY, RW ;

FISHKIN, EH ;

HENRY, DH ;

JACOBSON, RJ ;

JONES, SE ;

KELLER, AM ;

KUGLER, JW ;

NICHOLS, CR ;

SALMON, SE ;

SILVER, RT ;

STORNIOLO, AM ;

WAMPLER, GL ;

DOOLEY, CM ;

LARHOLT, KM ;

NELSON, RA ;

ABELS, RI .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (10) :801-806

[8]

CASH JM, 1989, AM J MED, V87, P639

[9]

DECAMPOS ES, 1991, BR J CANC S13, V63, P9

[10] RADIOTHERAPY AND ANEMIA - THE CLINICAL-EXPERIENCE [J].

DISCHE, S .

RADIOTHERAPY AND ONCOLOGY, 1991, 20 :35-40

← 1 2 3 4 5 →